Get a glimpse into our company and investor data—powered by the PitchBook Platform
Developer of drug candidates for the treatment of hypertension and epilepsy. The company's drug candidates are based on novel no-donor compounds that do not evoke pro-drug tolerance.
You’re viewing a free company profile from the PitchBook Platform. To explore Renopharm’s full profile, request a free trial.
© 2019 PitchBook Data. All rights reserved. PitchBook is a financial technology company that provides data on the capital markets.